Antifungal Drugs Industry In 2023, the global antifungal drugs market was valued at approximately USD 15.8 billion, with forecasts suggesting a compound annual growth rate (CAGR) of 3.8% from 2024 to 2030. This growth is significantly driven by the rising prevalence of fungal infections, including aspergillosis and candidiasis. Fungal infections encompass both systemic and superficial...

The global antifungal drugs market was valued at approximately USD 15.8 billion in 2023 and is forecasted to expand at a compound annual growth rate (CAGR) of 3.8% from 2024 to 2030. The increasing prevalence of fungal infections, such as aspergillosis and candidiasis, is a primary factor driving market growth. Fungal infections can range from systemic to superficial and include ailments...

The latest Antifungal Drugs Market Research Report published by Value Market Research gives in-depth analysis to show industry trends in the upcoming years.Furthermore, this report covers regional analysis comprising the segments, market size, trends, growth along with top players with their market share and strategic development.   This section of the antifungal drugs market...

The global antifungal drugs market size was estimated at USD 15.8 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 3.8% from 2024 to 2030. The growing prevalence of fungal infections such as aspergillosis and candidiasis is one of the key factors propelling the market. Fungal infections encompass both systemic and superficial infections...

Antifungal Drugs Industry Overview In 2023, the global antifungal drugs market was valued at approximately USD 15.8 billion, with forecasts suggesting a compound annual growth rate (CAGR) of 3.8% from 2024 to 2030. This growth is significantly driven by the rising prevalence of fungal infections, including aspergillosis and candidiasis. Fungal infections encompass both systemic and superficial...

The global antifungal drugs market size was estimated at USD 15.8 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 3.8% from 2024 to 2030. The growing prevalence of fungal infections such as aspergillosis and candidiasis is one of the key factors propelling the market. Fungal infections encompass both systemic and superficial infections...